Health
Farewell to hereditary baldness.. A new oral drug achieves "amazing" results for hair growth in just 6 months
The pharmaceutical company "Viradermix" announced good news for millions of people suffering from hair loss, by declaring the success of its advanced clinical trials on a new oral drug that promises a revolution in the treatment of pattern (hereditary) baldness, achieving noticeable hair density in just half a year.
The pharmaceutical company "Viradermix" (Viradermix) announced good news for millions of people suffering from hair loss, by declaring the success of its advanced clinical trials on a new oral drug that promises a revolution in the treatment of pattern (hereditary) baldness, achieving noticeable hair density in just half a year.
VDPHL01.. A Qualitative Leap After 30 Years of Stagnation
The new drug, coded VDPHL01, successfully passed phases II and III of clinical trials with remarkable success. If it obtains regulatory approval, it will be the first oral drug officially approved for the treatment of pattern baldness in three decades, becoming the fiercest competitor to "Finasteride".
Trial Results: Efficiency Exceeds 86%
The study included more than 500 men suffering from mild to moderate hair loss, and the numbers showed an overwhelming superiority of the new drug:
Remarkable Growth: 86% of participants reported clear hair growth, compared to only 36% for the placebo group.
Doubled Density: Two-thirds of participants (who took two doses daily) reported significant improvement in hair density and coverage of sparse areas.
High Safety: The 6-month trial proved that the drug is completely safe for the heart, with very minor side effects (such as fluid retention in only 5% of cases).
Why Does the New Drug Surpass Traditional Minoxidil?
For many years, "topical Minoxidil" (the spray) was the only solution, but it suffered from drawbacks that caused many to stop using it. Here are the advantages of VDPHL01:
Exclusive Formula: Not just an ordinary pill, but an "extended-release" formula that ensures stable drug levels in the blood, which enhances hair growth and reduces cardiovascular side effects.
Farewell to Topical Side Effects: It spares the user from the burning, redness, and sticky residue that the spray leaves on the scalp.
Pet Safety: It overcomes the problem of topical Minoxidil toxicity to cats and dogs, as it is an orally administered drug.
Promising Future for Hair Loss Treatments
"Viradermix" is currently preparing to submit the drug's file for official approvals, to be available in markets soon. This comes at a time when the medical field is witnessing the emergence of other promising drugs such as Clascoterone and PP405, heralding the end of the era of traditional baldness in the coming few years.
Summary: With measured doses and extended-release technologies, the dream of restoring lost hair with a "pill" seems closer than ever.
